Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · High-Yield Bond · Morgan Stanley

Calvert High Yield Bond Fund Calvert High Yield Bond Fund Class R6 (CYBRX)

Ticker CYBRX · Since 2019-02-01 · · Holdings as of Jun 30, 2026

Expense ratio
0.71%$71/yr per $10k
5-yr return
+3.6%annualized
1-yr return
+8.0%as of Dec 2025
Net assets
$531.6Mall share classes
Holdings
337

Bottom line

Is CYBRX a good fund? The bottom line

CYBRX is a share class of Calvert High Yield Bond Fund, a managed high-yield bond mutual fund from Morgan Stanley.

It charges 0.71% — about $71 a year on every $10,000 invested, cheaper than 53% of high-yield bond funds we track.

It returned +8.0% over one year, +3.6% a year over five years, +5.1% a year over ten (as of Dec 31, 2025, per its prospectus).

With $532 million in net assets and 337 holdings, its largest position is State Street Global Advisors (4.3%) and the top 10 make up 15.5% of the portfolio.

What stands out

  • Broadly diversified (337 holdings)
  • No front-end sales load

Updated Nov 19, 2026

What CYBRX invests in

The Funds investment objective is to seek high current income and capital appreciation, secondarily.

Under normal circumstances, the Fund invests at least 80% of its net assets (including borrowings for investment purposes) in high-yield, high-risk bonds, also known as junk bonds (80% Policy). The Fund invests primarily in high-yield, high-risk bonds with varying maturities, including distressed securities that are in default, which are rated lower than investment grade (i.e., bonds rated lower than Baa by Moodys Investors Service, Inc. (Moodys) or lower than BBB by S&P Global Ratings (S&P) or Fitch Ratings (Fitch)). For purposes of ratings restrictions, the average of S&P, Moodys and Fitch is used. The Funds duration and maturity is managed tactically based on the investment advisers outlook for the fixed-income markets. For its investments, the Fund seeks to identify high-yield bonds of companies that have the ability to make timely payments of principal and interest. Using…

From the fund's prospectus (filed Jan 27, 2026).

CYBRX performance

Average annual total returns
1 yr5 yr10 yr
CYBRX+8.0%+3.6%+5.1%
High-Yield Bond median+7.8%+4.0%+5.3%

Source: Fund prospectus, as of Dec 31, 2025

Full CYBRX performance history →

What CYBRX costs

On a $10,000 investment, CYBRX's 0.71% expense ratio costs about $71 a year. The prospectus estimates $883 in total costs over 10 years (assuming 5% annual returns). The median high-yield bond fund charges 0.74%.

See the full CYBRX fee table →

CYBRX top 10 holdings

#Holding% of fund
1State Street Global Advisors4.27%
2Morgan Stanley & Co. LLC3.69%
3Athenahealth Group Inc1.27%
4Greystar Real Estate Par1.08%
5Medline Borrower Lp1.03%
6California Buyer/atlanti1.03%
7Wand Newco 3 Inc0.88%
8Fortress Intermediate 3, Inc0.78%
9Cloud Software Grp Inc0.72%
10Somnigroup Intl Inc0.71%

Source: SEC Form N-PORT, period ended Jun 30, 2026

The top 10 make up 15.5% of the fund. See all top 25 holdings and asset mix →

Alternatives to CYBRX

More funds like CYBRX →

CYBRX FAQ

What is the expense ratio of CYBRX?
CYBRX's expense ratio is 0.71%, which works out to about $71 a year for every $10,000 invested. The prospectus estimates total costs of $883 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is CYBRX a good investment?
It depends on your goals, but the data points to: broadly diversified (337 holdings); no front-end sales load. This is general information, not personalized advice.
What does CYBRX hold?
CYBRX's largest holdings are State Street Global Advisors (4.3%), Morgan Stanley & Co. LLC (3.7%), Athenahealth Group Inc (1.3%), Greystar Real Estate Par (1.1%), Medline Borrower Lp (1.0%). It holds 337 positions in total as of Jun 30, 2026 (SEC Form N-PORT).
What is CYBRX's 5-year return?
CYBRX returned +3.6% a year over the five years ending Dec 31, 2025, and +5.1% a year over ten years. Past performance does not guarantee future results.
Does CYBRX have a sales load?
No. CYBRX has no front-end sales charge.
Who manages CYBRX?
CYBRX is offered by Morgan Stanley through Calvert Fund.